Motor neurone disease (MND) is an illness which robs away most of the movement of person and a patient suffering from the same dies within three years. There is a drug that patients having the disease can take, but it can also add only two to three months to their total life span.
A group of 22 scientists across Australia has received a grant of $2.2 million to study the disease. The funds have been raised by the MND Research Institute of Australia.
Main aim will be to know about the disease, to understand the causes and coming up with better ways to handle the disease. Treatment of the disease proves quite costly, said experts.
There are many cases in which a person has to spend more than a year's salary while the treatment is going on. Institute Chairman Professor Dominic Rowe affirmed that the disease is considered to be rare and this might be one of the reasons that it does not get needed financial support.
"The reason it is considered rare is that people die relatively quickly, so there are only about 2000 Australians living with it at any time", affirmed Rowe.
- J. Michael Pearson, Valeant’s Chief Executive Officer Spent Christmas in Hospital for ‘Severe’ Pneumonia
- Eversource Faces Stiff Challenge from ‘Society for the Protection of New Hampshire Forests’ over Burying Power Lines
- Shaw Communications Agree to Buy Wind Mobile for C$1.6 Billion
- Supporters of The Export-Import Bank in Congress make an Attempt to Revive It